Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00068393 2023-07-07

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Phase 2 Completed

39 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01164228 2023-06-15

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

87 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00121251 2021-04-06

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Phase 1/2 Completed

17 enrolled 13 charts

Genitourinary

Carcinoma, Renal Cell

NCT01762150 2018-11-20

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

Phase 2 Completed

26 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00496587 2017-07-19

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

Phase 2 Completed

34 enrolled 9 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00401128 2017-04-20

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

9 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00004095 2017-04-18

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

38 enrolled

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00630409 2017-03-10